Did you know that you can add speaker notes to each slide you create when using Microsoft PowerPoint? This allows you to add notes to each slide and then see them in Presenter View when you start ...

Slidebean is not just an alternative to PowerPoint and Keynote; it's a step up. Tome is an AI-powered presentation creator that goes beyond just designing slides. It serves as a collaborative AI ...

We all know that Microsoft’s PowerPoint software has been a presentations staple for a few decades now. And whether you only used it in school once or twice, or you use it for work on a daily ...

Just days after gene editor Tome Biosciences announced undisclosed operational cuts, a clearer picture is coming into focus as 131 employees are being laid off. The biotech, which emerged with $ ...

For a full version of this story and related coverage, visit STAT. High-profile gene editing startup Tome Biosciences said in a legal filing Friday that it will terminate virtually its entire ...

Tome Biosciences, a gene editing startup that launched in late 2023 with $213 million in funding, will eliminate 131 positions in November, according to a Worker Adjustment and Retraining Act notice.

Tome Bio­sciences, a high-pro­file gene edit­ing start­up, will ter­mi­nate near­ly its en­tire work­force dur­ing the first two weeks of No­vem­ber.

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

High-profile gene editing startup Tome Biosciences said in a legal filing Friday that it will terminate virtually its entire staff beginning Nov. 1. The Massachusetts WARN notice comes a day after ...

Despite the promise of its technology and funding from big backers, Tome Biosciences is “operating at reduced capacity” and weighing its “strategic options” as the Massachusetts-based company faces an ...

For most people, Microsoft's PowerPoint remains the original and ... firms need to get right from day one – from a good logo to a suitable font. CustomShow is business presentation software ...

Buzzy gene-editing startup Tome Biosciences is floundering, just nine months after launching with $213 million in funding, according to several sources with direct knowledge of the matter.